GJA1 and central nervous system cancer: Since many studies focused on Cx43 in gliomas, many new therapeutic targets have been proposed (e.g., Cx43 extracellular loop, Cx43 loop/tail interactions, Cx43 C-terminal) (Delvaeye et al., 2018).